The equity shares of Laurus Labs are likely to be listed on the exchanges effective from Mon, Dec 19, 2016. The shares would be listed on both BSE and NSE
The allotment of shares under the IPO was declared on Dec 15. Laurus Labs is in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.
IPO was subscribed 4.5 times on an overall basis with close to around 1.5 times subscription in the Retail category
No comments:
Post a Comment